Jon Zugazagoitia is a physician-scientist focused on lung
cancer. He is a faculty member and independent investigator at the 12 de
Octubre Hospital, and principal investigator of the Tumor Microenvironment and
Immunotherapy Research Group. His research interests are focused on the
discovery of biomarkers and mechanisms of sensitivity and resistance to
immunotherapy and targeted therapies for patients with lung cancer. He has an
h-Index of 20, and his papers have been cited more than 2300 times (Scopus, 1
November 2023).
Luis Paz-Ares is currently Chair of the Medical Oncology Department at the Hospital Doce de Octubre (University Hospital October 12), Associate Professor at the Universidad Complutense, and Head of the Lung Cancer Unit at the CNIO (National Oncology Research Center), all in Madrid, Spain. He graduated with a degree in medicine from the Universidad Autonoma de Madrid in 1986 and completed a PhD in 1993 at the same university. He was a postdoctoral ESMO Research Fellow in Medical Oncology at the Beatson Oncology Centre, University of Glasgow, Scotland (1993–1995), and completed a Master's degree in Clinical Pharmacology at the University of Glasgow in 1995. Luis Paz-Ares also completed a master's degree in Clinical Unit Management at the UNED-Fundación Universidad Empresa (2002–2003). Prior to his current position, he was Chair of the Medical Oncology Department at the Virgen del Rocío University Hospital in Seville (2007-2014), Head of the Pharmacology Unit, and responsible for early clinical studies of thoracic and genitourinary tumors at the University Hospital October 12 in Madrid (1995–1999; 2000–2007), and Visiting Research Fellow in the Prostate Cancer Program at the Dana-Farber Cancer Institute in Boston, Massachusetts, USA (1999–2000). His research focuses on lung cancer and the development of new therapeutic strategies both in the lab and the clinic.
